about
Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC).Revision of immunosuppression in a solid organ transplant recipient leads to complete remission of metastatic undifferentiated carcinoma
P50
description
researcher ORCID ID = 0000-0003-2957-3091
@en
wetenschapper
@nl
name
S Smith-Marrone
@ast
S Smith-Marrone
@en
S Smith-Marrone
@nl
type
label
S Smith-Marrone
@ast
S Smith-Marrone
@en
S Smith-Marrone
@nl
prefLabel
S Smith-Marrone
@ast
S Smith-Marrone
@en
S Smith-Marrone
@nl
P106
P31
P496
0000-0003-2957-3091